DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer

NEW HAVEN, Conn. and MONMOUTH JUNCTION, N.J., Aug. 30, 2022 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today announced the expansion of its management team by the appointment of Fred Knechtel as Chief Financial…

About the Author

has written 38955 stories on this site.

Copyright © 2010 Business and Corporate News.